C

CaroGen Corporation

9 employees

CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.

Basic info

Industry

biotechnology research

Sectors

vaccines
Biotechnology
Pharmaceutical
pharmaceuticals
Biopharma
viral vesicles
Health Care
Hepatitis B
immunotherapy
biotherapeutics
Colon Cancer
HBV
animal health vaccine
infectious disease

Date founded

2012

Funding rounds raised

Total raised

$1.4M

from 1 investors over 1 rounds

C

CaroGen Corporation raised $1.4M on March 27, 2019

Investors: National Institutes of Health

FAQ